How stigma can impact individuals with traumatic brain injury-related disability

Students' anxieties over participating in activities or completing tasks can be managed by increasing their motivation toward positive goals they want to achieve, a study has shown.

University of Massachusetts Amherst researchers and scientists at Embr Labs, a Boston-based start-up, have developed an AI-driven algorithm that can accurately predict nearly 70% of hot flashes before they're perceived. The work, featured in the journal Psychophysiology, will be incorporated into the Embr Wave, a wearable wrist device clinically proven to manage hot flashes.

Nearly 3 in 10 adults in the United States have experienced lower back pain in any three-month period, making it the most common musculoskeletal pain. Back pain remains one of the leading causes of disability worldwide, affecting millions and often leading to chronic discomfort, missed work and invasive procedures.

The development of many psychiatric disorders, including depression, schizophrenia and bipolar disorder, is known to be in great part influenced by genetics. Past research has identified various genes that appear to be associated with an increased risk of developing specific disorders, while also uncovering structural patterns commonly observed in the brains of affected individuals.

QUT researchers have created a prototype electronic device using a material made from seafood waste, paving the way for safe, flexible and sustainable wearable health sensors.

Researchers from Queen Mary University of London have developed and validated a new tool that could help GPs detect ovarian cancer earlier and improve patient outcomes cost-effectively.

What if your smart watch could sense when you're about to raid the fridge, and gently steer you toward a healthier choice instead?

Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, a potential breakthrough that could allow easier, community-based screenings for the world's deadliest infectious disease.

The U.S. is in the midst of an opioid epidemic; overdose deaths from synthetic opioids such as fentanyl have increased more than 100-fold since 1999. Medications like buprenorphine, methadone and naltrexone can all help treat opioid use disorder (OUD), curbing relapse, overdoses and death. But many barriers exist to people with OUD getting these medications, from providers not receiving adequate training to people with OUD feeling too stigmatized to find a specialist.

A new artificial intelligence model found previously undetected signals in routine heart tests that strongly predict which patients will suffer potentially deadly complications after surgery. The model significantly outperformed risk scores currently relied upon by doctors.

GLP-1 receptor agonists like Ozempic can be a lifeline for people with diabetes—helping stabilize blood glucose and lose weight, which contributes to diabetes complications. But not everyone benefits equally.

A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle-aged adults, suggests research published in the open access journal BMJ Public Health.

Mortality after emergency abdominal surgery is more than three times higher in the least developed countries compared to the most developed. Yet among those who undergo surgery, injuries tend to be less severe—raising concerns that those most critically injured are not even reaching the operating theater.

A lack of soap is the most often reported barrier to effective hand hygiene—key to curbing the spread of infection—in shared community spaces, such as households, schools, and public places, finds a systematic review of the available research, published in the open access journal BMJ Global Health.

A new international study presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts, with researchers uncovering the key factors driving this elevated risk.

Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity—a leading underlying cause of cardiovascular disease.

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Pharmaceutics.

New research has shown how harmful gambling is clearly linked to a marked and long-lasting increase in suicide attempts among young people in the UK.